Skip to content

Effectiveness of scapulothoracic exercise with myofeedback in patients shoulder complaints

Effectiveness of scapulothoracic exercise with myofeedback in patients shoulder complaints - ESTEEM study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46930
Enrollment
84
Registered
2018-11-01
Start date
2018-10-31
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bursitis of the shoulder tendonitis of the shoulder

Interventions

The eight week intervention will start directly after the baseline measurement. All treatments will be provided by one physical therapist. Each treatment session will take one hour. During the first
biofeedback
non-traumatic glenohumeral instability
shoulder
subacromial impingement syndrome

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 60 years; 2. Presence of scapular dyskinesis, defined as aymetrically moving scapulae during forward flexion or abduction. 3. Established diagnosis of SPS by physical therapist. diagnostic criteria voor subacromial shoulder pain: i. Presence of pain during active shoulder elevation. ii. Presence of pain during passive external rotation or isometric resistance against external rotation. iii. Presence of at least two positive test, from the following tests: Hawkins-Kennedy test, isometric resistance external rotation, painful arc test.

Exclusion criteria

Exclusion criteria: 1. Presence of any of the following items: a. Bilateral shoulder complaints. b. Traumatic onset of shoulder complaints. c. Duration of the shoulder complaints of more than nine months. d. History of one or more surgeries on either shoulder. e. Patient is on the waiting list for shoulder surgery. f. Presence of systemic diseases(for example diabetes, rheumatoid arthritis, COPD). g. Presence of neurological diseases (for example multiple slerosis, or other neurological diseases). 2. Presence of any of the following items in the physical examination a. A limitation of the range of motion of the glenohumeral joint compared to the heterolateral glenohumeral joint. b. Shoulder complaints which can be reproduced by cervical spine physical examination. c. Shoulder complaints which can be reproduced by thoracic spine physical examination. d. Positive horizontal adduction test. e. Positive lag test for any of the following muscles; M. Supraspinatus, M. Infraspinatus, M. Subscapularis. f. Positive tests for glenohumeral instability; apprenhension test, relocation test. 3. Inability to come to the physical therapy clinics for the duration of the intervention. 4. The use of paracetamol, or aspirine, or other non-steroidal anti-inflammatory drugs (ibuprofen, diclofenac, naproxen) during the treatment or refusing to discontinue the use of non-steroidal anti-inflammatory drugs during the study period; 5. Visus or cognitive limitations that inhibit the use of the sEMG devices. The potential participant needs to be able to clearly see, and interpret the screen of the sEMG devices/smartphones. For example blind patients will not be eligable for participation.

Design outcomes

Primary

MeasureTime frame
Primary outcome measures is the change self reported shoulder function measured with the Shoulder Pain And Disability Index.

Secondary

MeasureTime frame
Patient characteristics; age, gender, duration of complaints, smoking history, medication use. - Relative muscle onset time Relative muscle onset time will be measured using sEMG for the M. Trapezius Descendens, M. Trapezius Ascendens, M. Serratus Anterior. The muscle onset time will be measured relative to the M. Deltoid. Feedforward activity of the scapulothoracic muscles will be defined as activation of the M. Trapezius Ascendens or M. Serratus Anterior 100ms before to 50ms after M. Deltoid Anterior, in mili-seconds. - Maximum voluntary isometric contraction Maximum voluntary isometric contraction will be measured using a MicroFet (Hoggan Health Industries Inc, Utah, The United States of America) for the M. Trapezius Descendens, M. Trapezius Ascendens, M. Serratus Anterior, and M.Deltoid Anterior. - Patients pereived satisfaction We will use the Net Promotor Score to assess patient perceived satisfaction. Patient perceived satisfaction wil only be measured during the follow-up measurement. - Adherence Adherence to the exercise schedule will be tracked using a paper journal in all three groups. At each session the participant will receive a journal from the physical therapist performing the treatment. Then at the next session the journal can be handed in. Adherence will be expressed in percentages relative to the planned amount of exercises, sets, and repetitions to be completed.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)